Global Fund Faces Funding Gap Despite Replenishment Success

The Global Fund to Fight AIDS, Tuberculosis and Malaria recently concluded its Eighth Replenishment, raising US$12.64 billion. While many view this as a positive outcome, the result falls short of the organization’s US$18 billion target, raising concerns about the future of global health initiatives.

Eighth Replenishment Summit

The Eighth Replenishment Summit, held on November 21, 2025, in Johannesburg, South Africa, aimed to accelerate the fight against AIDS, tuberculosis, and malaria, while also strengthening health systems worldwide [The Global Fund]. South Africa and the UK co-hosted the event, emphasizing the importance of solidarity and sustainable innovation.

Falling Short of the Goal

Despite the substantial amount raised, the US$12.64 billion represents a significant gap compared to the initially sought US$18 billion. The Global Fund’s leadership had clearly indicated that the higher amount was achievable, and the investment case, published in The Lancet in July 2025, outlined the potential impact of such funding.

Projected Impact of Full Funding

According to research led by Tim Hallett and colleagues, an investment of US$18 billion, combined with domestic financing and other external donations, could have saved 23 million lives and prevented 400 million cases and infections between 2027 and 2029 [The Lancet]. The total resource needs for combating HIV, tuberculosis, and malaria during this period are estimated at US$140.6 billion [The Lancet].

Ongoing Research and Modeling

Researchers continue to refine models to understand the impact of Global Fund investments. For example, Tim Hallett (Imperial College London) is developing a case study for Malawi using the Thanzi La Onse model, while Tim Colbourn (University College London) is estimating the impact of Global Fund investments on oxygen-using Thanzi La Onse [Global Fund Advocates Network].

Looking Ahead

The shortfall in funding underscores the ongoing challenges in securing adequate resources for global health. While the US$12.64 billion will undoubtedly contribute to progress, it may limit the scale and impact of programs aimed at ending AIDS, tuberculosis, and malaria. Continued advocacy and innovative financing mechanisms will be crucial to bridge the funding gap and achieve ambitious global health goals.